7 ms·
Immunotherapy Is Changing Cancer Treatment Forever
- bookofjoe 2y agohttps://archive.ph/csOhz https://archive.ph/csOhz
- ranger_danger 2y ago[flagged]
- sugarpile 2y agoHeh. Do you use cloudflare DNS by any chance? archive.ph site owner doesn't like cloudflare not forwarding certain headers and fake captcha loops anyone using cloudflare dns
- croes 2y agoWould be quite ironic if parent uses cloudflare DNS
- aaomidi 2y agoOutrage culture.
- ranger_danger 2y agoI do not.
- itsTyrion 2y agothanks. even though "nymag" is a new name to me, I "reached my free article limit"
- michaelcampbell 2y agoSometimes adding a "." after the TLD (eg, nymag.com -> nymag.com.) in the URL works. It did for me on this one to avoid the popover.
- jseliger 2y agoThe biggest question in oncology today is whether this approach could also be used for solid tumors Yeah. I'm dying of a squamous cell carcinoma infestation: https://jakeseliger.com/2023/07/22/i-am-dying-of-squamous-cell-carcinoma-and-the-treatments-that-might-save-me-are-just-out-of-reach/ https://jakeseliger.com/2023/07/22/i-am-dying-of-squamous-ce... and the most recent clinical trial drug that was working, has stopped working: https://jakeseliger.com/2024/05/20/in-which-the-antibody-drug-conjugate-adc-pdl1v-shrinks-the-tumors-in-my-neck-and-buys-me-more-time/ https://jakeseliger.com/2024/05/20/in-which-the-antibody-dru.... One of the options for a next trial is from TScan, "A Basket Study of Customized Autologous TCR-T Cell Therapies." https://www.clinicaltrials.gov/study/NCT05973487?term=tscan002&rank=1 https://www.clinicaltrials.gov/study/NCT05973487?term=tscan0.... On the one hand, it looks very promising; on the other hand, lots of promising treatments fail during dose-escalation, first-in-human trials. To my knowledge, the first humans dosed with TScan's TCR-T therapy got it a few months ago. I got lucky, too, in that a slot for BGB-A3055 with Tislelizumab, an immunotherapy drug and trial, opened up at NEXT Oncology-Dallas: https://clinicaltrials.gov/study/NCT05935098?term=BGB-A3055&rank=1 https://clinicaltrials.gov/study/NCT05935098?term=BGB-A3055&.... One challenge, however, is that I received a bispecific antibody called petosemtamab from Sept 2023 to March 2024, then PDL1V (an antibody drug conjugate), and they're considered immunotherapies, so there's a question of whether continuing to pursue immunotherapies makes sense. By now the number of lines of therapy I've gotten make me ineligible for some trials: https://bessstillman.substack.com/p/the-drugs-killing-dying-patients https://bessstillman.substack.com/p/the-drugs-killing-dying-..., and I've also blown through the more promising drugs for what is a difficult-to-treat cancer type. It took just five years to get from their first promising results to FDA approval This sentence is insane. "Just?" It should be happening in months, not years. These are people with fatal diagnoses. Having the FDA hold up therapies like this is criminal.
- jonny_eh 2y agoAnd they're slow to avoid approving dangerous treatments, but that's absurd since the patients are already dying. The risk of not approving needs to be taken into account.
- 2y ago
- RyanAdamas 2y ago[flagged]
- vouaobrasil 2y agoIt's rather sick isn't it? Especially when curing cancer as a business benefits from an increase in technology which in turn is a producing of endless chemicals that end up in our drinking water and food and air.
- pfdietz 2y agoLet's aggregate all of society into a single thing and make everything equivalent. This cannot help but enable accurate understanding!
- Arrath 2y ago> Cancer is a for-profit business model where the owners of capital benefit from sickness. Sure, I'm with you here. > Curing cancer was never the goal. You're starting to lose me. Your statement might be correct for the most actuarial-brained monsters at the top of the executive foodchain but I think the research scientists and doctors would disagree with you. > Finding out how to give people cancer and treat it was. And here I think you've veered from legitimate criticism of the for-profit healtcare system into some serious whack conspiracy territory.
- Terr_ 2y agoIt also assumes the most-actuarial-brained monsters aren't worried about any competition from other monsters that can take their patients away with a better cure. While that's possible--ensuring competition is an ongoing issue in the American economy--it's still one more bad-star that has to align to get a real disaster*. *Yes, I know there's etymological repetition there and I like it.
- lencastre 2y ago[flagged]
- cdolan 2y agoIs there anything like this for ovarian cancer? Nearing the end of life for a family member
- dotcoma 2y agoMaybe this can help. https://www.clinicalnet.com/ https://www.clinicalnet.com/
- melling 2y agoI’m an amateur but have read a bunch about the new targeted therapies, like immunotherapy. Immunotherapy seems to only work in a small percentage of tumors with a lot of mutations. It’s easier to get your immune system to attack those. There are other targeted therapies depending on the genetic makeup of the tumor. BRAF, RAS, KRAS, NRAS, HER2, BRCA, … Maybe start here. There’s an incredible amount to learn. https://amp.cancer.org/cancer/types/ovarian-cancer/treating/targeted-therapy.html https://amp.cancer.org/cancer/types/ovarian-cancer/treating/... One really interesting advance is histotripsy which uses ultrasound to go after the cancer that has spread to your liver. https://histosonics.com/the-science/ https://histosonics.com/the-science/ Lots of informative YouTube videos. Look for ones by ASCO, Stanford, Mayo,MD Anderson, …
- toomuchtodo 2y agoAre you located anywhere near the University of Texas? There appears to be a protocol combining etigilimab and nivolumab. https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2021-08531 https://www.cancer.gov/research/participate/clinical-trials-... https://www.mdanderson.org/cancerwise/ovarian-cancer-survivor--an-immunotherapy-clinical-trial-saved-my-life.h00-159618645.html https://www.mdanderson.org/cancerwise/ovarian-cancer-survivo... Another potential protocol involves azenosertib in patients with high-grade serous ovarian, fallopian tube, or primary peritoneal cancer. https://www.onclive.com/view/dr-westin-on-early-findings-with-azenosertib-in-high-grade-serous-ovarian-cancer https://www.onclive.com/view/dr-westin-on-early-findings-wit... (not a doctor, not medical advice, just connecting dots, please take citations to a highly competent practitioner in this specific medicine domain such as the oncologist care provider/team of the patient you are advocating for, this is simply due diligence to prevent potential blindspots, we are all just human)
- Raydovsky 2y agoAnybody know why MRNA cancer vaccines didn't work out? seems like it's almost the same methodology in making the immune system target specific proteins.
- garbageman 2y agoThey might but if I recall MRNA stuff is pretty new - and getting the clinical trials through the entire process and approval takes quite a long time.
- vondur 2y agoLooks like doctors were able to treat brain cancer with a mRNA derived vaccine: https://ufhealth.org/news/2024/uf-developed-mrna-vaccine-triggers-fierce-immune-response-to-fight-malignant-brain-tumor https://ufhealth.org/news/2024/uf-developed-mrna-vaccine-tri...
- jsperx 2y agoAs somebody who unfortunately has a Stage IV diagnosis I have been researching mRNA and there have been promising results such as the MSK pancreatic study below, but still much to be ironed out — they had half the participants get a response but the other half nothing, even though each treatment was individually targeted and customized. They are doing a larger study now to try to see what other factors may be at play. https://www.mskcc.org/news/can-mrna-vaccines-fight-pancreatic-cancer-msk-clinical-researchers-are-trying-find-out https://www.mskcc.org/news/can-mrna-vaccines-fight-pancreati...
- adamredwoods 2y agomRNA vaccines need a target, and if there is a target, there are several approaches that already do this (anti-body drug conjugates), and sometimes work, sometimes doesn't. I don't think anybody thinks it "didn't work out". It's still actively ongoing: https://www.mdanderson.org/newsroom/md-anderson-curevac-enter-strategic-collaboration-develop-novel-cancer-vaccines.h00-159696756.html https://www.mdanderson.org/newsroom/md-anderson-curevac-ente... https://investors.modernatx.com/news/news-details/2023/Moderna-and-Merck-Announce-mRNA-4157V940-an-Investigational-Personalized-mRNA-Cancer-Vaccine-in-Combination-With-KEYTRUDAR-pembrolizumab-was-Granted-Breakthrough-Therapy-Designation-by-the-FDA-for-Adjuvant-Treatment-of-Patients-With-High-Risk-Melanom/default.aspx https://investors.modernatx.com/news/news-details/2023/Moder... (from 2021): https://link.springer.com/article/10.1186/s12943-021-01348-0/tables/1 https://link.springer.com/article/10.1186/s12943-021-01348-0... https://link.springer.com/article/10.1186/s12943-021-01348-0 https://link.springer.com/article/10.1186/s12943-021-01348-0
- Kalanos 2y agoYet investors and big pharma are both running away from immuno-oncology
- mettamage 2y agoWhy? Do you have some sources I could dig in to?
- bitwize 2y agoThe usual reasons: prolonged treatment is more profitable than a cure.
- biofox 2y agoThis doesn't apply when talking about terminal diseases like advanced cancer. Dead patients are the least profitable of all.
- rickydroll 2y agoMy brother committed suicide last February. His death was profitable for the funeral home. Anyone who manipulates a 90-year-old grieving mother deserves burn in several circles of hell.
- adamredwoods 2y agoThis is not true at all.
- Kalanos 2y agoMy sources are leading immuno-oncology pharma R&D teams and oncology VCs as recently as this week. I am launching an immuno-oncology therapeutics company.
- bollloga 2y agoCould this be helpful for neuroendocrine cancers?
- wwarner 2y agoWonderful article. I’m seeing two Nobels awarded for research into immunotherapy. Best of all, immunotherapy probably saved my sister from stage 4 cancer.
- duban 2y agoImmunotherapy saved my life, but sadly also made me an insulin dependent type 1 diabetic. (See https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10083744 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10083744 for more info about this side effect) I think immunotherapy is great and going to save many lives, but there are still some things that need to be worked out before it's perfect.
- elromulous 2y agoOf course on a completely different level, but I think this will be similar to how e.g. antibiotics or biologics have played out. First generation has awful side effects as researchers focus on getting anything to work at all. Then once a certain baseline of efficacy is reached, they can focus on reducing side effects.
- 01100011 2y agoYep, it wrecked my friend's thyroid and adrenals. I don't know what the drug was, but it was immunotherapy for stage iv melanoma.
- Sparkle-san 2y agoopdualag? I know someone who took it with lasting side effects.
- mcbain 2y agoThere's a bunch of different immuno types for melanoma (and other cancers). That one is a combo of nivolumab (aka Opdivo) and relatlimab. Nivo is used a lot for melanoma, also commonly in combo with ipi (ipilimumab, yervoy). Pembro (keytruda) is the other common one. Anyway, any of these can have adverse effects so patients are closely monitored. For me, my thyroid didn't like nivo much but recovered. But we stopped after a couple of cycles of ipi+nivo because I was starting to develop colitis. And more importantly it wasn't slowing development of my melanomas.
- noobermin 2y agoCancer really sucks like that. A lot the treatments definitely keep you alive and even cure you but leave you with nasty side effects. Oncologists measure changes in Quality of Life (QoL). When you have some kpi that attempts to model something as subjective as your quality of life you know it's quite bad already.
- elromulous 2y agoCan someone explain why it's taken so long to go from the success CAR-T had with non solid tumors, to getting an immunotherapy that indeed is effective against solid tumors?
- adamredwoods 2y ago"Success" for CAR-T is hazy, as many participants died from unrealized side effects, including new cancers. >> The FDA indicated that patients and participants in clinical trials receiving CAR T-cell therapy should be monitored life-long for secondary malignancies. https://www.onclive.com/view/fda-requires-boxed-warning-for-risk-of-t-cell-malignancies-with-approved-car-t-cell-therapies https://www.onclive.com/view/fda-requires-boxed-warning-for-... Regarding solid tumors, I've only hear about T-cell exhaustion, but CAR-T solid tumor trials are ongoing: https://med.stanford.edu/cancer/about/news/car-t-solid-tumor.html https://med.stanford.edu/cancer/about/news/car-t-solid-tumor... >> Although CAR T-cells directed toward the HER2-expressing tumors have been extensively studied in clinical trials, safety concerns have emerged following the death of a CRC patient who received 1×1010 third-generation HER2-CAR T-cells. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10067596/ https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10067596/
- borbulon 2y agoI was recently released from a clinical trial because of too many “newly measurable” areas of tumor. I was offered CAR-T but was told that it comes with a high risk of possibly fatal infections and is not guaranteed to work at all for my cancer (HER-2 positive lung cancer, stage 4). I turned it down. I have a wife and 3 kids, I’d rather spend an unknown amount of time being fully present with them than risk my life today.
- Lauralvarez 2y ago[dead]
- adamredwoods 2y agohttps://www.onclive.com/view/fda-requires-boxed-warning-for-risk-of-t-cell-malignancies-with-approved-car-t-cell-therapies https://www.onclive.com/view/fda-requires-boxed-warning-for-...
- aaronblohowiak 2y agoI applaud your courage. Take videos for your kids.
- low_tech_love 2y agoIs this really a good idea? I’ve been thinking about doing this for a while, but a part of me tells me it’d just be weird and morbid for them, and maybe interfere in their ability to let me go and live their life to the fullest. I don’t mean videos of us together doing stuff (I.e. memories) but videos meant directly for them to watch. I’m thinking about giving them advice for adulthood and telling them about who I am, and also tell them about who they are as kids (so they can remember it after they grow up). But I’m still not convinced it’s a good idea.
- throwaway7ahgb 2y agoDon't make it morbid then? Just talk to them and let them get to know who you are. That itself is incredibly difficult as most people can't describe who they are beyond their name and title.
- DaoVeles 2y agoMy father is in his mid 70's with bladder cancer and is now going down the immunotherapy path completely aware that this is still essentially a new thing with bugs to be figured out. At this point the best we are hoping for is a few more years but understand if it doesn't work out. It is still wild to see where we are going. While I am skeptical of many technological claims that get thrown around nowadays, medical advances are still plodding along wonderfully. Even if at times it can be two steps forward, one step back.
- chmorgan_ 2y agoI follow Vinay Prasad MD (https://www.youtube.com/@vprasadmdmph https://www.youtube.com/@vprasadmdmph), who does a lot of research related to medical studies and methodology, lots of cancer related ones as that's an area where he works. You'd be surprised at the number of cancer treatment studies that are deeply flawed: - Positive effects may have a low confidence due to small sample size, the joke is that if you can fit the laser pointer between the lines it's considered a success. Cancer is a very tough disease and sometimes positive results are due to noise in the dataset. - Some studies don't consider overall survival (important because you might not die of cancer but you might die sooner from a side effect like Parkinson's caused by the treatment). See mammograms and colonoscopies for treatments that look like they are almost entirely ineffective. - Don't compare against the standard of care (its easier to show positive results if you aren't using the best treatments available) - Allow for self selection (the treatment isn't blind or double blind and people drop out of the control group, skewing the results) Imo he's an excellent source of the latest data driven results related to cancer and other treatments.
- thenerdhead 2y agohttps://www.panaccindex.info/p/profile-ucsfs-vinay-prasad https://www.panaccindex.info/p/profile-ucsfs-vinay-prasad
- rob74 2y agoSo, a COVID denialist/anti-vaxxer trying to find a new field of activity?
- ggm 2y agoI believe Mammograms and Colonoscopies are diagnostic techniques not treatments per se. It is possible you are conflating the rise of over-diagnosis, and mis-diagnosis from improvements in imaging, and the consequent rise in colonoscopies and removal of polyps.
- seizethegdgap 2y agoMy wife has Stage 2(B?) triple negative breast cancer (TNBC). Her treatment regiment includes Keytruda (pembrolizumab) once every 21 days. There was a full trial she was told about that is exploring using pembrolizumab entirely without chemo for TNBC. It's incredible that we might soon have at least one cancer that we might not need chemo to treat.
- noobermin 2y agoPeople are now taking TKI inhibitors as first line treatments. It doesn't really cure you, but given long term stable disease, you could end up with late stage cancer patients who don't need chemo for years. TKIs are for very rare lung cancers but they're quite effective for late stage cancer patients whom have the right type of tumor mutations.
- yread 2y agoThere are a few de-escalation trials where patients with high amount of lymphocytes in tumor associated stroma don't need to get chemo, even for stage 2 and 3 TNBC
- bettercallsalad 2y agoIs there any potential for immunotherapy for stage IV metastatic castration resistant prostate cancer?
- amy-petrik-214 2y agoImmunotherapy is not some wonder drugs. It's been around for some time as far as cutting edge is concerned, obviously quite new compared to the 1980s chemo revolution. By "been around by quite some time" I mean there are quite a number of immunotherapy drugs, and follow-on "me-too" competitors, and lots of 2nd and 3rd and 4th generation drugs. THe only reason it may seem brand spanking new to you, is dunning kruger effect. It's quite expensive and doesn't always work. We have predictors of whether it works well or not, but nothing has stuck. It's very hard because cancer is hard and immune system is hard, and this is both. THis whole thing about "immunotherapy is new and has bugs to figure out" is half true, but hell, if "bugs" mean that it doesn't work, the whole reason immunotherapy exists is because the things that came before also had these "bugs" ie people dying. Every cancer is different. Every cancer is different in every different person. THere are common trends, common genes, common themes, absolutely, but every cancer is different just like every person every face is different. At best you can get a common drug targeting common genes and common themes, just like you could target people with brown hair, but if you happened to have blonde hair you're out of luck until they cook up a solution for that. This is the nature of cancer and where there is no universal cure. also this board is pretty dang comp sci heavy, and comp sci and physics the instinct is 1000% dunning kruger within the realm of biology or other extraneous inferior-appearing fields. BIology is the most rabbit hole ridden field. The rabbit holes have rabbit holes, and they have their own rabbit holes. You're thinking about cancer but maybe it relates to some evolutionary resistance that was necessary 200 million years ago, and that relates to a biochemical pathway protein binding side. It's a polymath's wet dream really. So it's important not to hand wave or give airs of understanding it. I've been specializing in the area for many years and I can say that nobody understands it really, other than that it works sometimes with some various correlates of when it works. Like most parts of bio, people will specialize in one compenent of the system or one pathway, not the system as a whole. People who claim to capture the system as a whole kinda do interesting things but they don't have the detailed big picture, more like various correlates that are frought with confounders
- dfgdgf 2y ago[flagged]
- ChrisVogel 2y agoIn 2009 I received a stem cell transplant for mantle cell lymphoma. After about eight years it was discovered in my stomach and I was on the very expensive drug Imbruvica. That lasted until the fall of 2022 when I crashed. I started the CAR T process in October ‘22 and the transplant was done late March ‘23. It was a long recovery “expect about a year” but I’m now doing well, playing tennis and golf and lots of energy for many activities. I’m lucky. I’ll be 70 in October, male and don’t have any chronic complications.
- CVogelsang 2y agoIn 2009 I received a stem cell transplant for mantle cell lymphoma. After about eight years it was discovered in my stomach and I was on the very expensive drug Imbruvica. That lasted until the fall of 2022 when I crashed. I started the CAR T process in October ‘22 and the transplant was done late March ‘23. It was a long recovery “expect about a year” but I’m now doing well, playing tennis and golf and lots of energy for many activities. I’m lucky. I’ll be 70 in October, male and don’t have any chronic complications.
- Lauralvarez 2y ago[dead]